Pharma Industry News

January 13 2023 – Novo Nordisk’s GLP-1 for Type II diabetes approved for first-line treatment

Written by David Miller

Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment
Roche searches for pharma chief Anderson's successor from within
Novavax CEO Erck bids adieu after 12 years
Three TIGIT players look to surprise in 2023
*please scroll down for all the latest news*
Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches:

image: Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]